Dr. Christina Marie Charles-Schoeman, MD

Dr. Charles-Schoeman practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Charles-Schoeman's NPI, 1467486993, was assigned on July 10, 2006. Dr. Charles-Schoeman graduated from David Geffen School of Medicine at UCLA in 2000. Dr. Charles-Schoeman's California license number on file is A78257.

Dr. Charles-Schoeman's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Charles-Schoeman's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Charles-Schoeman is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Charles-Schoeman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Charles-Schoeman practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Charles-Schoeman's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Charles-Schoeman is board certified in rheumatology by the American Board of Internal Medicine. Dr. Charles-Schoeman has a license on file in California.

Dmand AI lists arthritis, lupus, muscle disease and rheumatoid arthritis among the conditions Dr. Charles-Schoeman treats.

CMS data shows 166 Medicare services from Dr. Charles-Schoeman across 2 procedure codes in 2024, all of them office visits, for 82 Medicare patients. Medicare paid $16,936 for them.

CMS counts 82 Medicare patients who saw Dr. Charles-Schoeman in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have arthritis, and 72% have high blood pressure. 34% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Charles-Schoeman's median patient age at 58, with 72% women.

In 2024, Dr. Charles-Schoeman wrote 1,002 Medicare Part D claims for 72 patients. 50% of them were for generic drugs. CMS names the drug for 887 of them, across 20 drugs with 11 or more claims each, at $3,577,447 in total drug cost. In 2023, CMS named 871 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Charles-Schoeman for performance year 2024, reported as part of a group. Dr. Charles-Schoeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Charles-Schoeman as offering telehealth.

Dmand AI links 9 papers to Dr. Charles-Schoeman in 2011. 2011 was the busiest year, with 2. Dr. Charles-Schoeman's most frequent co-authors are John Dermot Fitzgerald, MD, Alan Howard Gorn, MD and Maureen Anne McMahon, MD.

Dmand AI links Dr. Charles-Schoeman to 6 clinical trials. 2 are still active or recruiting. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Dermatomyositis. Sanofi sponsors the most, 2. Open Payments lists research payments to Dr. Charles-Schoeman that name 6 trials.

CMS Open Payments shows 319 general payments to Dr. Charles-Schoeman from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Pfizer Inc. paid the most, $96,074. It also lists 55 research payments totaling $54,162 from 2017 to 2023, naming 6 clinical trials.

Dmand AI lists 2 awards for Dr. Charles-Schoeman, most recently CMS Stage 1 EHR in 2013.

Dr. Charles-Schoeman graduated from David Geffen School of Medicine at UCLA in 2000. Dr. Charles-Schoeman is a member of ACR.

Dr. Charles-Schoeman is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.